Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level

Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal Carcinoma: A big-data intelligence platform-based analysis

(2018) Hao Peng et al.   ORAL ONCOLOGY

A Retrospective Study to Compare Five Induction Chemotherapy Regimens Prior to Radiotherapy in the Reduction of Regional Lymph Node Size in Patients with Nasopharyngeal Carcinoma

(2018) Jing Chen et al.   MEDICAL SCIENCE MONITOR

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial

(2017) Su-Mei Cao et al.   EUROPEAN JOURNAL OF CANCER

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

(2016) Ying Sun et al.   LANCET ONCOLOGY

Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up

(2015) Meng-Xia Zhang et al.   EUROPEAN JOURNAL OF CANCER

Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma

(2015) Lin-Quan Tang et al.   JNCI-Journal of the National Cancer Institute

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

(2015) Pierre Blanchard et al.   LANCET ONCOLOGY

Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma

(2015) Lin-Quan Tang et al.   JNCI-Journal of the National Cancer Institute

Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fr

(2014) Anne W.M. Lee et al.   CANCER

Non-endemic locoregionally advanced nasopharyngeal carcinoma: long-term outcome after induction plus concurrent chemoradiotherapy in everyday clinical practice

(2014) Paolo Boscolo-Rizzo et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma

(2014) Junlin Yi et al.   Radiation Oncology

Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trials

(2013) P. Y. OuYang et al.   ANNALS OF ONCOLOGY

Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patients

(2013) Xueming Sun et al.   Radiation Oncology

Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities

(2013) Xueming Sun et al.   RADIOTHERAPY AND ONCOLOGY

A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma

(2012) Gang Peng et al.   RADIOTHERAPY AND ONCOLOGY

Is nasopharyngeal cancer really a "Cantonese cancer"?

(2012) Joseph Tien Seng Wee et al.   Chinese Journal of Cancer

Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer

(2011) P. Bossi et al.   ANNALS OF ONCOLOGY

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

(2011) Jochen H Lorch et al.   LANCET ONCOLOGY

Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases

(2010) Shaojun Lin et al.   BMC CANCER

Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma

(2010) Mario Airoldi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

(2010) Anne W.M. Lee et al.   EUROPEAN JOURNAL OF CANCER

Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation

(2009) Y. Pointreau et al.   JNCI-Journal of the National Cancer Institute

Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma

(2008) Edwin P. Hui et al.   JOURNAL OF CLINICAL ONCOLOGY

Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma

(2008) Anne W.M. Lee et al.   RADIOTHERAPY AND ONCOLOGY